PARP Inhibitors in BRCA Gene-Mutated Ovarian Cancer and Beyond.
- Published in:
- Current Oncology Reports, 2011, v. 13, n. 6, p. 442, doi. 10.1007/s11912-011-0193-9
- By:
- Publication type:
- Article
Works matching IS 15233790 AND DT 2011 AND VI 13 AND IP 6
Results: 9
1
2
The Role of Radiotherapy in Endometrial Cancer: Current Evidence and Trends.
- Published in:
- Current Oncology Reports, 2011, v. 13, n. 6, p. 472, doi. 10.1007/s11912-011-0191-y
- By:
- Publication type:
- Article
3
What is the Role of Chemotherapy in Endometrial Cancer?
- Published in:
- Current Oncology Reports, 2011, v. 13, n. 6, p. 433, doi. 10.1007/s11912-011-0192-x
- By:
- Publication type:
- Article
4
Adoptive T-Cell Therapy of Melanoma Using Designer T-Cell Receptors.
- Published in:
- Current Oncology Reports, 2011, v. 13, n. 6, p. 427, doi. 10.1007/s11912-011-0196-6
- By:
- Publication type:
- Article
5
Treatment of Advanced Melanoma with Immunological Checkpoint Block.
- Published in:
- Current Oncology Reports, 2011, v. 13, n. 6, p. 430, doi. 10.1007/s11912-011-0195-7
- By:
- Publication type:
- Article
6
Immunobiology of Merkel Cell Carcinoma: Implications for Immunotherapy of a Polyomavirus-Associated Cancer.
- Published in:
- Current Oncology Reports, 2011, v. 13, n. 6, p. 488, doi. 10.1007/s11912-011-0197-5
- By:
- Publication type:
- Article
7
Anti-angiogenic Agents in Ovarian Cancer: Dawn of a New Era?
- Published in:
- Current Oncology Reports, 2011, v. 13, n. 6, p. 450, doi. 10.1007/s11912-011-0194-8
- By:
- Publication type:
- Article
8
The 'SWOT' of BRAF Inhibition in Melanoma: RAF Inhibitors, MEK Inhibitors or Both?
- Published in:
- Current Oncology Reports, 2011, v. 13, n. 6, p. 479, doi. 10.1007/s11912-011-0198-4
- By:
- Publication type:
- Article
9
Recurrent Ovarian Cancer: When and How to Treat.
- Published in:
- Current Oncology Reports, 2011, v. 13, n. 6, p. 459, doi. 10.1007/s11912-011-0199-3
- By:
- Publication type:
- Article